Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: Aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2573-2575

  Mulatero, Paolo ^a   Veglio, Franco ^a   Pilon, Catia ^c   Rabbia, Franco ^a   Zocchi, Cristina ^a   Limone, Paolo ^b   Boscaro, Marco ^c   Sonino, Nicoletta ^c   Fallo, Francesco ^c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Department of Medical and Surgical Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DEXAMETHASONE;

ADULT; AGED; CHIMERA; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SOUTHERN BLOTTING;

EID: 0031757967     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.7.4946     Document Type: Review

References (31)

1. Sutherland DJ, Ruse JL, Laidlaw JC. 1966 Hypertension, increased aldosterone secretion, and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 95:1109-1119.
2. Fallo F, Mantero F. 1990 Dexamethasone-suppressible hyperaldosteronism. In: Biglieri EG, Melby JC, eds. Endocrine hypertension. Comprehensive endocrinology, revised series. New York: Raven Press; 87-92.
3. Litchfield WR, Coolidge C, Silva P, et al. 1997 Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 82:1507-1510.
4. Litchfield WR, Dluhy RG. 1996 Glucorticoid-remediable aldosteronism. Curr Opin Endocrinol Diabetes. 3:265-270.
5. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. 1994 Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD, ed. Textbook of hypertension. Oxford: Blackwell; 865-892.
6. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG. 1997 Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab. 82:3570-3573.
7. Ulick S, Blumenfield JD, Atlas SA, Wang JZ, Vaughan Jr D. 1993 The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 76:873-878.
8. Carroll J, Dluhy R, Fallo F, et al. 1996 Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications. J Clin Endocrinol Metab. 81:4310-4312.
9. Lifton RP, Dluhy RG, Powers M, et al. 1992 A chimeric 11-β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 355:262-265.
10. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon R. 1995 A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun. 207:565-571.
11. Litchfield WR, Dluhy RG. 1995 Primary aldosteronism. Endocrinol Clin North Am. 24:593-612.
12. Vallotton MB. 1996 Primary aldosteronism. 1. Diagnosis of primary hyperaldosteronism. Clin Endocrinol (Oxf). 45:47-52.
13. Pascoe L, Curnow KM, Slutsker L, et al. 1992 Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA. 89:8327-8331.
14. Lifton RP, Dluhy RG, Powers M, et al. 1992 Hereditary hypertension caused by chimeric gene duplications and ectopic expression of aldosterone synthase. Nat Gen. 2:66-74.
15. Pascoe L, Jeunemaitre X, Lebrethon MC, et al. 1995 Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 96:2236-2246.
16. Fallo F, Sonino N, Armanini D, et al. 1985 A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II. Clin Endocrinol (Oxf). 22:777-785.
17. Jeunemaitre X, Charru A, Pascoe L, et al. 1995 Hyperaldostéronisme sensible à la dexaméthasone avec adénome surrénalien. Presse Med. 24:1243-1248.
18. Jamieson A, Slutsker L, Inglis G, et al. 1995 Clinical, biochemical and genetic features of five extended kindreds with glucocorticoid-suppressible hyperaldosteronism. Endocr Res. 21:463-469.
19. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. 1995 Primary aldosteronism: some genetic, morphological, and biochemical aspects of subtypes. Steroids. 60:35-41.
20. Dluhy RG, Lifton RP. 1996 Phenotypic variation in glucocorticoid remediable aldosteronism (GRA). In: New MI, ed. Where phenotype does not match genotype. Ares-Serono Symposia Series Frontiers in Endocrinology. Rome: Ares-Serono; vol 16:81-90.
21. Stowasser M, Bachmann AW, Jonsson JR, Tunny TJ, Klemm SA, Gordon RD. 1995 Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. J Hypertens. 13:1610-1613.
22. Pascoe L, Curnow KM. 1995 Genetic recombination as a cause of inherited disorders of aldosterone and Cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids. 60:22-27.
23. 320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme. Nat Struct Biol. 4:32-35.
24. Irony I, Kater CE, Biglieri EG, Shackleton CHL. 1990 Correctable subset of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens. 3:576-582.
25. Mantero F, Armanini D, Boscaro M, et al. 1991 Steroids and hypertension. J Steroid Biochem Mol Med. 40:35-44.
26. Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ. 1976 The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism. J Lab Clin Med. 88:261-270.
27. Schambelan M, Brust NML, Chang BCF, Slater KL, Biglieri EG. 1976 Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab. 43:115-131.
28. Ganguly A, Chavarri M, Luetscher JA, Dowdy AJ. 1977 Transient fall and subsequent return of high aldosterone secretion during continued dexamethasone administration. J Clin Endocrinol Metab. 44:775-779.
29. Wenting GJ, Man In't Veld AJ, Derkx FH, Brummelen PV, Schalekamp MADH. 1978 ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism. J Clin Endocrinol Metab. 46:326-335.
30. Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos G, Allolio B. 1997 Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression. Clin Endocrinol (Oxf). 46:619-626.
31. Hoefnagels WHL, Kloppenborg PWC. 1982 Hazards of long-term dexamethasone treatment in primary aldosteronism. N Engl J Med. 306:427.